Welcome to PsychU!

Mobile Apps For Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Digital Health Sensors For Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Log In

Medication Adherence Technology For Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Telepsychiatry In Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Clinical Decision Support System For Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Digital Assessments & Interventions For Mental Healthcare: Potential Benefits & Guidelines

You must be logged-in to view this content.

Benefits & Challenges Of Smartphone Use In Mental Health

Pew Research Center statistics indicate that 95% of Americans now own some type of cellphone, and that 77% are smartphones.1 …

You must be logged-in to view this content.

The Opioid Crisis: Perspectives From Addiction Specialists In Primary Care & Psychiatry

The United States is currently experiencing an opioid epidemic, impacting health care providers across all specialties, including those working in …

You must be logged-in to view this content.

Tools To Assess & Address Medication Adherence In Patients With Serious Mental Illness

Poor medication adherence presents a significant barrier to successful treatment and recovery in patients with serious mental illness and can …

You must be logged-in to view this content.

Treating Insomnia May Lead To Improvements In Mental Health Symptoms

You must be logged-in to view this content.

Clinical & Economic Impact Of Bipolar Disorder

You must be logged-in to view this content.

Comorbid Medical Illness In Bipolar Disorder

You must be logged-in to view this content.

The Role Of Brain Structure & Function In The Association Between Inflammation & Depressive Symptoms: A Systematic Review

You must be logged-in to view this content.

Self-Perceived Cognitive Deficits & Their Relationship With Internalized Stigma & Quality Of Life In Patients With Schizophrenia

You must be logged-in to view this content.

Comorbid Anxiety Increases Cognitive Control Activation In Major Depressive Disorder

You must be logged-in to view this content.

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

You must be logged-in to view this content.

Ten-Year Outcomes Of First-Episode Psychoses In The MRC ÆSOP-10 Study

You must be logged-in to view this content.

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

You must be logged-in to view this content.

Coping Strategies & Self-Stigma In Patients With Schizophrenia-Spectrum Disorders

You must be logged-in to view this content.

The Neurobiology Of Motivational Deficits In Depression – An Update On Candidate Pathomechanisms

You must be logged-in to view this content.

Anxiety Symptoms In A Major Mood & Schizophrenia Spectrum Disorders

You must be logged-in to view this content.

Training To Enhance Psychiatrist Communication With Patients With Psychosis (TEMPO): Cluster Randomised Controlled Trial

You must be logged-in to view this content.

Functional Impairment In Patients With Major Depression In Clinical Remission: Results From The VIVAL-D-Rem, A Nationwide, Naturalistic, Cross-Sectional Survey

You must be logged-in to view this content.

Genetic Determinants Of Depression: Recent Findings & Future Directions

You must be logged-in to view this content.

Impact Of Non-Remission Of Depression On Costs & Resource Utilization: From The Comorbidities & Symptoms Of Depression (CODE) Study

You must be logged-in to view this content.

Clinical Value Of Early Partial Symptomatic Improvement In The Prediction Of Response & Remission During Short-Term Treatment Trials In 3,369 Subjects With Bipolar I Or II Depression

You must be logged-in to view this content.

Available Screening Tools For Adults Suffering From Bipolar Affective Disorder In Primary Care: An Integrative Literature Review

You must be logged-in to view this content.

Health Technology Intervention After Hospitalization For Schizophrenia: Service Utilization & User Satisfaction

You must be logged-in to view this content.

Recovery & Recurrence Following A First Episode Of Mania: A Systematic Review & Meta-Analysis Of Prospectively Characterized Cohorts

You must be logged-in to view this content.

Associations Between Diabetes, Major Depressive Disorder & Generalized Anxiety Disorder Comorbidity, & Disability: Findings From The 2012 Canadian Community Health Survey – Mental Health (CCHS–MH)

You must be logged-in to view this content.

Pharmacogenomics & Personalized Medicine: Where Are We Now & Where Are We Going?

In this webinar, Henry A. Nasrallah, MD and Rifaat El-Mallakh, MD, review foundational concepts related to the cytochrome p-450 system …

You must be logged-in to view this content.

Covariates Of Depression & High Utilizers Of Healthcare: Impact On Resource Use & Costs

You must be logged-in to view this content.

Cerebral White Matter Structure Is Associated With DSM-5 Schizophrenia Symptom Dimensions

You must be logged-in to view this content.

Smartphone Applications For Mental Health

You must be logged-in to view this content.

Neuroinflammation & White Matter Pathology In Schizophrenia: Systematic Review

You must be logged-in to view this content.

Cognitive Impairment In Manic Bipolar Patients: Important, Understated, Significant Aspects

You must be logged-in to view this content.

Late-Life Depression & Cardiovascular Disease Burden: Examination Of Reciprocal Relationship

You must be logged-in to view this content.

Epidemiology Of Depression & Diabetes: A Systematic Review

You must be logged-in to view this content.

Duration Of Untreated Depression Influences Clinical Outcomes & Disability

You must be logged-in to view this content.

Predictors Of Impaired Work Functioning In Employees With Major Depression In Remission

You must be logged-in to view this content.

Neuroplasticity Underlying The Comorbidity Of Pain & Depression

You must be logged-in to view this content.

Current & Remitted Depression & Anxiety Disorders As Risk Factors For Medication Nonadherence

You must be logged-in to view this content.

Brain Structural Abnormalities In Patients With Major Depression With Or Without Generalized Anxiety Disorder Comorbidity

You must be logged-in to view this content.

Neuroinflammation & Psychiatric Illness

You must be logged-in to view this content.

Genetics Of Schizophrenia & Smoking: An Approach To Studying Their Comorbidity Based On Epidemiological Findings

You must be logged-in to view this content.

Genetic Correlates Of Medical Comorbidity Associated With Schizophrenia & Treatment With Antipsychotics

You must be logged-in to view this content.

When Social Anxiety & Depression Go Together: A Population Study Of Comorbidity & Associated Consequences

You must be logged-in to view this content.

Stigma & Discrimination Experienced By People Living With Severe & Persistent Mental Illness In Assertive Community Treatment Settings

You must be logged-in to view this content.

Looking Beyond Mood & Psychosis: A Focus On Neurocognition

Historically, cognitive impairment was considered an artifact of patients’ symptoms, attention, or motivation problems, and as such, was an underappreciated …

You must be logged-in to view this content.

The CANMAT Task Force Recommendations For The Management Of Patients With Mood Disorders & Comorbid Medical Conditions: Diagnostic, Assessment, & Treatment Principles

Key Messages

This review article examined evidence that supports a bidirectional relationship between medical illness and mood disorders. This relationship involves …

You must be logged-in to view this content.

Rates & Predictors Of Remission, Recurrence & Conversion To Bipolar Disorder After the First Lifetime Episode Of Depression – A Prospective 5-Year Follow-Up Study

You must be logged-in to view this content.

Depressive Residual Symptoms Are Associated With Lower Adherence To Medication In Bipolar Patients Without Substance Use Disorder: Results From The FACE-BD Cohort

You must be logged-in to view this content.

Diagnosis Of Bipolar Disorder In Primary & Secondary Care: What Have We Learned Over A 10-Year Period?

You must be logged-in to view this content.

Risk Factors For Suicide In Bipolar Disorder: A Systematic Review

Key Messages

Bipolar disorder (BD) has the highest rate of suicide among the major psychological disorders. The risk for death by …

You must be logged-in to view this content.

Depression & Risk Of Mortality In Individuals With Diabetes: A Meta-Analysis & Systematic Review

You must be logged-in to view this content.

Theories Of Bipolar Disorder Pathophysiology

This video is part 2 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews some …

You must be logged-in to view this content.

Integrated Care: Navigating The Evolving Health Care System In 2017

The health care landscape continues to be dynamic in 2017. Part of the evolving system involves primary care providers coordinating …

You must be logged-in to view this content.

Cognitive Functions In Bipolar Manic, Depressed & Remission Episodes

You must be logged-in to view this content.

Negative Symptoms & Functioning During The First Year After A Recent Onset Of Schizophrenia & Eight Years Later

You must be logged-in to view this content.

The Presentation, Recognition & Management Of Bipolar Depression In Primary Care

You must be logged-in to view this content.

Dealing With Stigma In Mental Health: Are We Making Progress?

Individuals living with mental health conditions can face significant stigma, not only from the public, but also from health care …

You must be logged-in to view this content.

Retention Of Bipolar Disorder Diagnosis After Childhood

You must be logged-in to view this content.

DSM-5: Bipolar Disorder Diagnosis With Major Depressive Disorder

You must be logged-in to view this content.

PTSD & Trauma In Bipolar Disorder

You must be logged-in to view this content.

Rating Scales For Bipolar Disorder

You must be logged-in to view this content.

Diet, Exercise & Sleep For Patients With Bipolar Disorder

You must be logged-in to view this content.

miR-1202: A Primate-Specific & Brain-Enriched miRNA Involved In Major Depression & Antidepressant Treatment

You must be logged-in to view this content.

Engaged Practice: Methods For Managing The Complexity Of Bipolar Disorder & Related Conditions

It can be challenging for psychiatrists to provide confident diagnoses and treatment of patients with bipolar disorder and related conditions, …

You must be logged-in to view this content.

Impending Signs Of Psychosis: Focus On Caregiver & Patient Engagement

The majority of individuals who experience psychosis in schizophrenia will eventually relapse, making an individual’s ability to identify early warning …

You must be logged-in to view this content.

Advanced Receptor Psychopharmacology

This video is part 3 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Neurotransmitter Functioning In Major Depressive Disorder

This video is part 1 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video introduces …

You must be logged-in to view this content.

Advanced Neurotransmitters & Neuroglia

This video is part 2 of a series on Basic & Advanced Concepts In Psychopharmacology, from the Psychopharmacology Collection. This …

You must be logged-in to view this content.

Clinical Application Of Psychopharmacology Of Major Depressive Disorder – Chris Bojrab, MD

This interview with Chris Bojrab, MD, is part 3 of the 3-part module series on Major Depressive Disorder (MDD), from …

You must be logged-in to view this content.

Potential Role Of Neurotransmitters & Treatment Considerations In Bipolar Disorder

This video is part 1 of a series on Bipolar Disorder, from the Psychopharmacology Collection. This video briefly reviews the proposed …

You must be logged-in to view this content.

Pharmacologic Treatments In Major Depressive Disorder

This video is part 2 of a series on Major Depressive Disorder (MDD), from the Psychopharmacology Collection. This video provides …

You must be logged-in to view this content.

Follow Up Q&A – Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

During this question and answer session, Henry A. Nasrallah, MD and Roger Sommi, PharmD, BCPP, FCCP respond to unanswered questions …

You must be logged-in to view this content.

Treatment Of Schizophrenia: Focus On Psychopharmacology & Adherence

While treating to remission is the goal in schizophrenia, it remains a target not achieved for many patients. In this …

You must be logged-in to view this content.

Immunology Of Major Depression

You must be logged-in to view this content.

Glial Abnormalities In Substance Use Disorders & Depression: Does Shared Glutamatergic Dysfunction Contribute To Comorbidity?

You must be logged-in to view this content.

The Diagnosis & Treatment Of Bipolar Disorder: Decision-Making In Primary Care

You must be logged-in to view this content.

Characteristic Distributions Of Regional Cerebral Blood Flow Changes In Major Depressive Disorder Patients: A Pseudo-Continuous Arterial Spin Labeling (pCASL) Study

You must be logged-in to view this content.

The Comorbidity Between Depression & Diabetes

You must be logged-in to view this content.

Inflammation In Neurological & Psychiatric Diseases

You must be logged-in to view this content.

Does Screening For Depression In Primary Care Improve Outcome?

You must be logged-in to view this content.

Type 1 Diabetes Mellitus & Major Depressive Disorder: Evidence For A Biological Link

You must be logged-in to view this content.

Total & Differential White Blood Cells Counts, High-Sensitivity C-Reactive Protein, & Cardiovascular Risk In Non-Affective Psychoses

You must be logged-in to view this content.

Auditory Dysfunction In Schizophrenia: Integrating Clinical & Basic Features

You must be logged-in to view this content.

The Potential Of Immune Biomarkers To Advance Personalized Medicine Approaches For Schizophrenia

You must be logged-in to view this content.

Bridging The Gap Between Primary Care & Psychiatry In The Treatment Of MDD: A Discussion Among Nurses

While collaboration between primary care and psychiatry is a goal in treating mental illness, there remains significant opportunities for improvement. …

You must be logged-in to view this content.

Is It MDD Or Bipolar Disorder? (Distinguishing Bipolar Series Part 1)

Two noted experts present this webinar on appropriately diagnosing Major Depressive Disorder (MDD) and Bipolar Disorder, two disorders that can …

You must be logged-in to view this content.

Pharmacokinetics: The Basics

You must be logged-in to view this content.

An Overview Of Treatment Options & Cost For Schizophrenia

You must be logged-in to view this content.

Follow Up Q&A – Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis

During this question and answer session, Rebecca Roma, MD and Robert Nelson, MD, respond to unanswered questions from their webinar …

You must be logged-in to view this content.

Co-Occurrence Of Substance Use Disorders With Mood Disorders & Psychosis

During this webinar Rebecca Roma, MD, Medical Director of the Community Treatment Team at Mercy Behavioral Health; and Robin Nelson, …

You must be logged-in to view this content.

Meeting The Challenges In Caring For Patients With Schizophrenia: Roles Of The Pharmacist

Addressing the challenges of caring for patients with schizophrenia in terms of treatment, recovery, and remission requires a coordinated effort …

You must be logged-in to view this content.

Correlates Of Real World Executive Dysfunction In Bipolar I Disorder

You must be logged-in to view this content.

Does GP Training In Depression Care Affect Patient Outcome? A Systematic Review & Meta-Analysis

You must be logged-in to view this content.

Suicide Risk In Individuals With Bipolar Disorder Is Higher Than In Individuals With Major Depressive Disorder (MDD)

We know that suicide risk is a major concern in those suffering from mental illnesses such as major depression. Can …

You must be logged-in to view this content.

The 3 Top Challenges Of Treating A Patient With Bipolar Disorder

You must be logged-in to view this content.

The Pros & Cons Of Treatment Guidelines For Bipolar Disorder

You must be logged-in to view this content.

Residual Symptoms Are Strong Predictor Of Relapse In Patients With Bipolar Disorder

You must be logged-in to view this content.

The First Episode Of Bipolar Disorder May Predict Course Of Illness

You must be logged-in to view this content.

Individuals With Bipolar Disorder Have A 20- To 30-Fold Increased Risk Of Suicide

Can you discuss the risk of suicide in regard to those individuals with bipolar disorder?

Individuals with bipolar disorder have a …

You must be logged-in to view this content.

Depression, Serotonin & Tryptophan

You must be logged-in to view this content.

Collaborative Treatment Approaches & Perspectives Of Major Depressive Disorder (MDD) Within The North Carolina Healthcare Landscape

On October 26th, 2016, PsychU sponsored a live symposium titled “Collaborative Treatment Approaches & Perspectives Of Major Depressive Disorder (MDD) …

You must be logged-in to view this content.

Collaborative Treatment Approaches & Perspectives Of Major Depressive Disorder (MDD) Within The Los Angeles Healthcare Landscape

You must be logged-in to view this content.

Summary Of Stigma Survey Results Utilizing The Opening Minds Stigma Scale For Health Care Providers (OMS-HC)

You must be logged-in to view this content.

Public Health Significance Of Bipolar Disorder: Implications For Early Intervention & Prevention

You must be logged-in to view this content.

Bipolar Disorder: Importance Of Residual Symptoms & Impact On Outcomes

Patients with bipolar disorder often live with residual symptoms even when responding to treatment. In this webinar, Mauricio Tohen, MD, …

You must be logged-in to view this content.

Misdiagnosis, Duration Of Untreated Illness (DUI) & Outcome In Bipolar Patients With Psychotic Symptoms: A Naturalistic Study

You must be logged-in to view this content.

Future Of Psychopharmacology: Is New Treatment Innovation Still Alive?

While past decades saw a boom in the development of innovative new treatments in the field of psychiatry, the pace …

You must be logged-in to view this content.

Stigma In Mental Health: Breaking Down Barriers & Uncovering Opportunities

For individuals living with mental health disorders, stigmatization can form a barrier to seeking help and achieving recovery and social …

You must be logged-in to view this content.

Cost Of Illness For Bipolar Disorder: A Systematic Review Of The Economic Burden

You must be logged-in to view this content.

Glutamate Metabolism In Major Depressive Disorder

You must be logged-in to view this content.

An Individualized Risk Calculator For Research In Prodromal Psychosis

You must be logged-in to view this content.

Unraveling The Mechanisms Responsible For The Comorbidity Between Metabolic Syndrome & Mental Health Disorders

You must be logged-in to view this content.

Achieving The Triple Aim Through Innovations In Care Management: Improving The Value Of Care In Mental Health

The health care needs of people with comorbid behavioral and medical disorders are not always met by traditional delivery models; …

You must be logged-in to view this content.

Rethinking The Genetic Basis For Comorbidity Of Schizophrenia & Type 2 Diabetes

You must be logged-in to view this content.

The Prospective Long-Term Course Of Adult Depression In General Practice & The Community. A Systematic Literature Review

You must be logged-in to view this content.

Screening, Evaluation & Management Of Depression In People With Diabetes In Primary Care

You must be logged-in to view this content.

The Overlap Between Anxiety, Depression, & Obsessive-Compulsive Disorder

You must be logged-in to view this content.

Age Of Onset Of Bipolar Disorder: Combined Effect Of Childhood Adversity & Familial Loading Of Psychiatric Disorders

You must be logged-in to view this content.

The Neurobiology Of Bipolar Disorder: Neuroimaging & Genetics Update

You must be logged-in to view this content.

Determinants Of Adherence To Treatment In Bipolar Disorder: A Comprehensive Review

You must be logged-in to view this content.

Duration Of Untreated Bipolar Disorder: Missed Opportunities On The Long Road To Optimal Treatment

You must be logged-in to view this content.

Opening Minds Scale For Health Care Providers (OMS-HC-15)

You must be logged-in to view this content.

Is Zero A Must?: The Impact Of Residual Symptoms In Major Depressive Disorder

While remission is the goal in treatment of patients with major depressive disorder (MDD), persistent symptoms are common, even among …

You must be logged-in to view this content.

Absolute Measurements Of Macrophage Migration Inhibitory Factor & Interleukin-1-β mRNA Levels Accurately Predict Treatment Response In Depressed Patients

You must be logged-in to view this content.

The Plasma Levels of Various Cytokines Are Increased During Ongoing Depression & Are Reduced to Normal Levels After Recovery

You must be logged-in to view this content.

Anxiety Comorbidity in Schizophrenia

You must be logged-in to view this content.

The Role Of White Matter Abnormalities In Treatment-Resistant Depression: A Systematic Review

You must be logged-in to view this content.

Practice-Based Interventions Addressing Concomitant Depression & Chronic Medical Conditions In The Primary Care Setting: A Systematic Review & Meta-Analysis

You must be logged-in to view this content.

A Meta-Review Of Lifestyle Interventions For Cardiovascular Risk Factors In The General Medical Population: Lessons For Individuals With Serious Mental Illness

You must be logged-in to view this content.

Phenotypically Distinct Subtypes of Psychosis Accompany Novel or Rare Variants in Four Different Signaling Genes

You must be logged-in to view this content.

Telepsychiatry: Enhancing Access to Mental Health Care

Despite advances in care, there remain several barriers to patient access to optimal mental health care. Telepsychiatry, a form of …

You must be logged-in to view this content.

Depression & Cardiovascular Disease

You must be logged-in to view this content.

Cerebral Metabolism In Major Depressive Disorder: A Voxel-Based Meta-Analysis Of Positron Emission Tomography Studies

You must be logged-in to view this content.

Toll-Like Receptor 4: Innate Immune Regulator Of Neuroimmune & Neuroendocrine Interactions In Stress & Major Depressive Disorder

You must be logged-in to view this content.

The Potential Role Of Monocyte Chemoattractant Protein-1 For Major Depressive Disorder (MDD)

You must be logged-in to view this content.

Multimorbidity, Depression, & Mortality In Primary Care: Randomized Clinical Trial Of An Evidence-Based Depression Care Management Program On Mortality Risk

You must be logged-in to view this content.

Risk Factors Associated With Psychiatric Readmission

You must be logged-in to view this content.

Serotonin 1A & Serotonin 4 Receptors: Essential Mediators Of The Neurogenic & Behavioral Actions Of Antidepressants

You must be logged-in to view this content.

Comorbidity Of Late-Life Depression In The United States: A Population-Based Study

You must be logged-in to view this content.

Mobile Mental Health: Is There an App for That?

You must be logged-in to view this content.

Follow Up Q&A – Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Provider (PCP) & A Psychiatrist

You must be logged-in to view this content.

Managing Metabolic Wellness In The Mentally Ill: Perspectives From Both A Primary Care Physician (PCP) & A Psychiatrist

Metabolic wellness is an extremely important consideration in treating patients with schizophrenia, who have an increased incidence of cardiometabolic risk …

You must be logged-in to view this content.

Cognitive Dysfunction In Depression — Pathophysiology & Novel Targets

You must be logged-in to view this content.

Sensor Technologies To Help Monitor & Manage Your Patients

You must be logged-in to view this content.

Readmission Patterns & Effectiveness of Transitional Care Among Medicaid Patients With Schizophrenia & Medical Comorbidity

You must be logged-in to view this content.

Scaling-Up Treatment Of Depression & Anxiety: A Global Return On Investment Analysis

You must be logged-in to view this content.

Antidepressant Drug Development: Focus On Triple Monoamine Reuptake Inhibition

You must be logged-in to view this content.

Patient Engagement In Mental Health: Strategies To Improve Care

Patient engagement is an important issue in mental illness. Studies have reported that 18-67% of patients with mental illness failed …

You must be logged-in to view this content.

What Are Residual Symptoms in Schizophrenia Spectrum Disorder? Clinical Description & 1-Year Persistence Within a Naturalistic Trial

You must be logged-in to view this content.

Integrating Behavioral Health Into Primary Care

You must be logged-in to view this content.

Understanding & Addressing Medication Adherence In Psychiatry

Medication adherence is of great importance in optimizing outcomes in psychiatry, however definitions and understanding of adherence have evolved over …

You must be logged-in to view this content.

Clinically Useful Anxiety Outcome Scale (CUXOS)

You must be logged-in to view this content.

Metabolic Syndrome In Bipolar Disorder & Schizophrenia: Dietary & Lifestyle Factors Compared To The General Population

You must be logged-in to view this content.

Defining Therapeutic Benefit For People With Schizophrenia: Focus On Negative Symptoms

You must be logged-in to view this content.

First Outpatient Follow-up After Psychiatric Hospitalization: Does One Size Fit All?

You must be logged-in to view this content.

Cognitive Functions In First-Episode Depression & Recurrent Depressive Disorder

You must be logged-in to view this content.

Optimizing Mental & Physical Health Outcomes Through Comprehensive Medication Management

Medication-related problems cost the United States $290 billion per year in avoidable medical spending. In this webinar, Terry McInnis, MD …

You must be logged-in to view this content.

Schizophrenia—A Medical Psychiatric Syndrome

You must be logged-in to view this content.

Recovery In The Community: Can We Do Better?

A goal for all patients with mental illness should be symptom reduction and optimal psychosocial functioning. In this webinar, experienced …

You must be logged-in to view this content.

Reduction Of Patient-Reported Antidepressant Side Effects In Collaborative Care

You must be logged-in to view this content.

A Longitudinal Examination Of The Moderating Effects Of Symptoms On The Relationship Between Functional Competence & Real World Functional Performance In Schizophrenia

You must be logged-in to view this content.

Identifying Predictors, Moderators, & Mediators Of Antidepressant Response In Major Depressive Disorder: Neuroimaging Approaches

You must be logged-in to view this content.

Co-Occurring Psychotic & Addictive Disorders: Neurobiology & Diagnosis

You must be logged-in to view this content.

Approaches To Improve Adherence To Pharmacotherapy In Patients With Schizophrenia

You must be logged-in to view this content.

Major Depressive Disorder: Understanding The Significance Of Residual Symptoms & Balancing Efficacy With Tolerability

You must be logged-in to view this content.

New Hypothesis & Treatment Targets Of Depression: An Integrated View Of Key Findings

You must be logged-in to view this content.

Psychiatric Care Of The Older Adult: An Overview For Primary Care

You must be logged-in to view this content.

Suboptimal Response In Psychotic & Mood Disorders: Causes, Consequences, & Management Strategies

Suboptimal response is a common challenge and can lead to negative consequences for patients diagnosed with serious mental illness. In …

You must be logged-in to view this content.

The Role Of NMDA Receptors In The Pathophysiology & Treatment Of Mood Disorders

You must be logged-in to view this content.

Measurement-Based Scales In Major Depressive Disorder: Implementing Patient-Reported Outcome Scales With The Goal Of Improving Treatment Outcomes

You must be logged-in to view this content.

Moving Toward Integrated Behavioral Intervention For Treating Multimorbidity Among Chronic Pain, Depression, & Substance-Use Disorders In Primary Care

You must be logged-in to view this content.

Measuring Performance In Psychiatry: A Call To Action

You must be logged-in to view this content.

An Overview Of The Clinically Useful Depression Outcome Scale (CUDOS)

You must be logged-in to view this content.

Inflammation, Heart Disease, & Depression

You must be logged-in to view this content.

Major Depressive Disorder: Burden & Impact Beyond The Sufferer

Major depressive disorder (MDD) is a debilitating disease that affects approximately 7% of adults in the US. In this webinar, experienced …

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder

During this recorded presentation, David Scheiderer, MD, provided a brief overview of the psychopharmacology of major depressive disorder. Key points …

You must be logged-in to view this content.

Collaborative Care For Patients With Depression & Diabetes Mellitus: A Systematic Review & Meta-Analysis

You must be logged-in to view this content.

A Foundational Approach To The Treatment Of Schizophrenia

Schizophrenia is a chronic and devastating illness, affecting more than 21 million people globally. In this webinar, experienced psychiatrists Noel …

You must be logged-in to view this content.

The Importance Of Norepinephrine In Depression

You must be logged-in to view this content.

A Collaborative Approach To Care Coordination For Patients With Schizophrenia: Perspectives From Nursing & Social Work

Many patients with schizophrenia fail to transition from inpatient settings to community mental health settings. In this webinar, Brooke Kempf …

You must be logged-in to view this content.

Detection & Characteristics Of Individuals With A Very Long Duration Of Untreated Psychosis In An Early Intervention For Psychosis Service

You must be logged-in to view this content.

Clinical Correlates Of Initial Treatment Disengagement In First-Episode Psychosis

You must be logged-in to view this content.

Who Is Paying The Price? Loss Of Health Insurance Coverage Early In Psychosis

You must be logged-in to view this content.

Is Early Intervention For Psychosis Feasible & Effective?

You must be logged-in to view this content.

Inflammation & The Two-Hit Hypothesis Of Schizophrenia

You must be logged-in to view this content.

The Cytokine Model of Schizophrenia: Emerging Therapeutic Strategies

You must be logged-in to view this content.

Comprehensive Versus Usual Community Care For First-Episode Psychosis: 2-Year Outcomes From The NIMH RAISE Early Treatment Program

You must be logged-in to view this content.

Pathways To (Specialized) Care: Patient Costs & Contacts En Route To A First-Episode Psychosis Clinic

You must be logged-in to view this content.

Severity Of Psychosis Syndrome & Change Of Metabolic Abnormality In Chronic Schizophrenia Patients: Severe Negative Syndrome May Be Related To A Distinct Lipid Pathophysiology

You must be logged-in to view this content.

Using Measurement Strategies to Identify & Monitor Residual Symptoms

You must be logged-in to view this content.

Quantifying Clinical Relevance: Introducing Effect Sizes

You must be logged-in to view this content.

The Economic Impact Of Depression: Resistance Or Severity?

You must be logged-in to view this content.

Understanding The Role Of Neurotransmitters In The Treatment Of Depression

Major depressive disorder (MDD) is common, affecting an estimated 16 million US adults each year. However, less than 40% of …

You must be logged-in to view this content.

The Nurse’s Role In Primary Care Antidepressant Medication Adherence

You must be logged-in to view this content.

Collaborative Care To Improve The Management Of Depressive Disorders: A Community Guide Systematic Review & Meta-Analysis

You must be logged-in to view this content.

The Role Of Pro-inflammatory Cytokines In Neuroinflammation, Neurogenesis & The Neuroendocrine System In Major Depression

You must be logged-in to view this content.

Evolving Psychiatry: Technology For Patient Care

In this webinar, brief overviews of digital technology in psychiatry are presented by leading expert David Mohr, PhD, Director at …

You must be logged-in to view this content.

Depression As A Risk Factor For Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review & Recommendations: A Scientific Statement From The American Heart Association

You must be logged-in to view this content.

The Economic Burden Of Adults With Major Depressive Disorder In The United States (2005 & 2010)

You must be logged-in to view this content.

A Review Of The Clinical, Economic, & Societal Burden Of Treatment-Resistant Depression: 1996-2013

You must be logged-in to view this content.

Neurotransmitter Targeting In The Treatment Of Depression

You must be logged-in to view this content.

Management Of Major Depressive Disorder: Breaking Through The Barriers

You must be logged-in to view this content.

Recognizing & Responding To Inadequately Treated Major Depressive Disorder (MDD): A Nursing Perspective

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

Early Intervention In Psychosis: Benefits, Barriers, & Best Practices

You must be logged-in to view this content.

Measuring Outcome In The Treatment Of Depression: Why You Should Do It & How You Can Do It – A Focus On Measurement-Based Care

Major depressive disorder (MDD) is a serious, chronic disabling illness, with residual symptoms causing significant psychosocial and occupational functional impairment. …

You must be logged-in to view this content.

The Contribution Of Major Depression To The Global Burden Of Ischemic Heart Disease: A Comparative Risk Assessment

You must be logged-in to view this content.

The Neurobiology Of Relapse In Schizophrenia

You must be logged-in to view this content.

Developing A Cognitive Training Strategy For First-Episode Schizophrenia: Integrating Bottom-Up & Top-Down Approaches

You must be logged-in to view this content.

Presence Of Individual (Residual) Symptoms During Depressive Episodes & Periods Of Remission: A 3-Year Prospective Study

You must be logged-in to view this content.

The Role Of Pro-Inflammatory Cytokines In The Neuroinflammation & Neurogenesis Of Schizophrenia

You must be logged-in to view this content.

How Should Residual Symptoms Be Defined in Depressed Patients Who Have Remitted?

You must be logged-in to view this content.

Residual Symptoms & Functioning In MDD, Does The Type Of Residual Symptom Matter? A Post-Hoc Analysis

You must be logged-in to view this content.

Acute & Chronic Stress Exposure Predicts 1-Year Recurrence In Adult Outpatients With Residual Depression Symptoms Following Response To Treatment

You must be logged-in to view this content.

The Evolving Psychopharmacology Of Major Depressive Disorder: Narrowing The Treatment Gap

Depression is a widespread condition estimated to affect millions of adults in the United States alone. Despite the significant burden …

You must be logged-in to view this content.

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

Agitation is frequently seen in patients with schizophrenia. When treating acute agitation in these patients, minimizing sedation should be a …

You must be logged-in to view this content.

Managing The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

You must be logged-in to view this content.

Early Intervention For Psychotic Disorders In A Community Mental Health Center

You must be logged-in to view this content.

Reducing Duration Of Untreated Psychosis: Care Pathways To Early Intervention In Psychosis Services

You must be logged-in to view this content.

Impact Of Major Depressive Disorder On Patients, Caregivers, Payers, & Employers

You must be logged-in to view this content.

Management Of Major Depressive Disorder (MDD): Breaking Through The Barriers

An estimated 1 in 10 US adults report depression, with major depressive disorder (MDD) as common as diabetes or coronary …

You must be logged-in to view this content.

An Overview Of The Brief Adherence Rating Scale (BARS)

You must be logged-in to view this content.

Clinical Relevance Of Fatigue As A Residual Symptom In Major Depressive Disorder

You must be logged-in to view this content.

Long-Term Follow-Up Of The TIPS Early Detection In Psychosis Study: Effects On 10-Year Outcome

You must be logged-in to view this content.

Treating The Patient With Schizophrenia: Striking A Balance Between Symptom Control & Tolerability

Psychosis is ranked as one of the top three most disabling conditions worldwide. Quality of life is commonly impaired in …

You must be logged-in to view this content.

Disengagement From Mental Health Treatment Among Individuals With Schizophrenia & Strategies For Facilitating Connections To Care: A Review Of The Literature

You must be logged-in to view this content.

Residual Symptoms & Relapse: Mood, Cognitive Symptoms, & Sleep Disturbances

You must be logged-in to view this content.

Impact Of Early Intervention Services On Duration Of Untreated Psychosis: Data From The National EDEN Prospective Cohort Study

You must be logged-in to view this content.

Burden Of Depressive Disorders By Country, Sex, Age, & Year: Findings From The Global Burden Of Disease Study 2010

You must be logged-in to view this content.

Global Burden Of Disease Attributable To Mental & Substance Use Disorders: Findings From The Global Burden Of Disease Study 2010

You must be logged-in to view this content.

Reduction In Incidence Of Hospitalizations For Psychotic Episodes Through Early Identification & Intervention

You must be logged-in to view this content.

The Effect Of Prolonged Duration Of Untreated Depression On Antidepressant Treatment Outcome

You must be logged-in to view this content.

Reducing The Duration Of Untreated Psychosis & Its Impact In The U.S.: The STEP-ED Study

You must be logged-in to view this content.

The Brief Adherence Rating Scale (BARS) Validated Against Electronic Monitoring In Assessing The Antipsychotic Medication Adherence Of Outpatients With Schizophrenia & Schizoaffective Disorder

You must be logged-in to view this content.

Importance Of Remission & Residual Somatic Symptoms In Health-Related Quality Of Life Among Outpatients With Major Depressive Disorder: A Cross-Sectional Study

You must be logged-in to view this content.

Towards A Pragmatic & Operational Definition Of Relapse In Schizophrenia: A Delphi Consensus Approach

You must be logged-in to view this content.

Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

You must be logged-in to view this content.

Early Intervention In Psychosis: Benefits, Barriers & Best Practices

Psychosis is ranked as one of the top three most disabling conditions worldwide, with a longer duration of untreated psychosis …

You must be logged-in to view this content.

Residual Symptoms In Major Depressive Disorder: Prevalence, Effects, & Management

You must be logged-in to view this content.

“Sometimes It’s Difficult To Have A Normal Life”: Results From A Qualitative Study Exploring Caregiver Burden In Schizophrenia

You must be logged-in to view this content.

Exploratory Analysis Of Social Cognition & Neurocognition In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Review Of International Early Psychosis Programmes & A Model To Overcome Unique Challenges To The Treatment Of Early Psychosis In The United States

You must be logged-in to view this content.

The Impact Of Premorbid Adjustment, Neurocognition & Depression On Social & Role Functioning In Patients In An Early Psychosis Treatment Program

You must be logged-in to view this content.

Prevention & Recovery In Early Psychosis (PREP®): Building A Public-Academic Partnership Program In Massachusetts, United States

You must be logged-in to view this content.

Facilitating Recovery In Schizophrenia: An Assertive Community Treatment Approach

Why is the concept of recovery important to patients with schizophrenia? What are some barriers to recovery? How can an …

You must be logged-in to view this content.

Unmet Needs In The Management Of Schizophrenia

You must be logged-in to view this content.

Effectiveness Of Continuity-Of-Care Programs To Reduce Time In Hospital In Persons With Schizophrenia

You must be logged-in to view this content.

Why Do Some Depressed Outpatients Who Are In Remission According To The Hamilton Depression Rating Scale Not Consider Themselves To Be In Remission?

You must be logged-in to view this content.

The STRIDE Weight Loss & Lifestyle Intervention For Individuals Taking Antipsychotic Medications: A Randomized Trial

You must be logged-in to view this content.

The Mental Health Quality Forum: An Ecosystem Approach To Quality – Part 1: Identifying The Barriers To Quality & Part 2: Guiding Development Of Pilot Projects To Drive Quality Improvement

You must be logged-in to view this content.

Continuity Of Antipsychotic Medication Management For Medicaid Patients With Schizophrenia

You must be logged-in to view this content.

Social Cognition As A Mediator Between Neurocognition & Functional Outcome In Individuals At Clinical High Risk For Psychosis

You must be logged-in to view this content.

Continuity Of Care After Inpatient Discharge Of Patients With Schizophrenia In The Medicaid Program: A Retrospective Longitudinal Cohort Analysis

You must be logged-in to view this content.

Individual & Contextual-Level Factors Associated With Continuity Of Care For Adults With Schizophrenia

You must be logged-in to view this content.

Depression & Cardiovascular Disease: An Update On How Course Of Illness May Influence Risk

You must be logged-in to view this content.

Can Medication Management Coordinators Help Improve Continuity Of Care After Psychiatric Hospitalization?

You must be logged-in to view this content.

Economics Of Collaborative Care For Management Of Depressive Disorders: A Community Guide Systematic Review

You must be logged-in to view this content.

Distinguishing Sedation From Efficacy In Antipsychotic Treatment

You must be logged-in to view this content.

Risk Factors For Treatment Resistance In Unipolar Depression: A Systematic Review

You must be logged-in to view this content.

Schizophrenia Genetics: Emerging Themes For A Complex Disorder

You must be logged-in to view this content.

What Needs To Follow Early Intervention? Predictors Of Relapse & Functional Recovery Following First-Episode Psychosis

You must be logged-in to view this content.

Quality Of Life In A 20-Year Follow-Up Study Of People Suffering From Schizophrenia

You must be logged-in to view this content.

Metabolic Wellness Considerations In Schizophrenia

You must be logged-in to view this content.

Healthcare Providers’ Attitudes Toward Persons With Schizophrenia

You must be logged-in to view this content.

Lifestyle Management Of Unipolar Depression

You must be logged-in to view this content.

Nonadherence With Antipsychotic Medication In Schizophrenia: Challenges & Management Strategies

You must be logged-in to view this content.

Does Relapse In Schizophrenia Cause Neurodegeneration? A Simulcast Debate & Webinar To Explore The Evidence

There is a continuous debate in the mental health community around the progressive nature of schizophrenia as a disease: Is …

You must be logged-in to view this content.

Different & Shared Brain Volume Abnormalities In Late- & Early-Onset Schizophrenia

You must be logged-in to view this content.

The Affordable Care Act (ACA) & Mental Health

You must be logged-in to view this content.

Diagnostic & Statistical Manual Of Mental Disorders–Fifth Edition (DSM-5): Key Updates VS DSM-IV-TR

You must be logged-in to view this content.

Looking Through The Lens: Understanding Schizophrenia Through Neuroimaging

You must be logged-in to view this content.

Antipsychotic Medication Nonadherence: Risk Factors & Remedies

You must be logged-in to view this content.

Patient Empowerment To Improve The Quality Of Patient Care

You must be logged-in to view this content.

Recognizing & Responding To Inadequately Treated Major Depressive Disorder (MDD)

You must be logged-in to view this content.

Integration of Depression & Primary Care: Barriers To Adoption

You must be logged-in to view this content.

Comorbidity & Its Relevance On General Hospital Based Mortality In Major Depressive Disorder: A Naturalistic 12-Year Follow-up In General Hospital Admissions

You must be logged-in to view this content.

Twelve Months Of Electronic Monitoring (MEMS®) In The Swedish COAST-Study: A Comparison Of Methods For The Measurement Of Adherence In Schizophrenia

You must be logged-in to view this content.

Should Full Adherence Be A Necessary Goal In Schizophrenia? Full Versus Non-Full Adherence To Antipsychotic Treatment

You must be logged-in to view this content.

How To Increase Medication Adherence: What Works?

Key Messages

Pharmacists may be in a unique position to influence and educate psychiatric patients on a regular basis regarding medication …

You must be logged-in to view this content.

Medication Adherence In Schizophrenia

You must be logged-in to view this content.

Assertive Community Treatment: Bridging The Gaps In The Community

You must be logged-in to view this content.

Updates In Schizophrenia: Research, Remission, & Recovery

You must be logged-in to view this content.

Psychometric Properties Of The Questionnaire About The Process Of Recovery (QPR)

You must be logged-in to view this content.

Is Personal Recovery In Schizophrenia Predicted By Low Cognitive Insight?

You must be logged-in to view this content.

Fear Of Recurrence: Results Of A Randomized Trial Of Relapse Detection In Schizophrenia

You must be logged-in to view this content.

Design & Validation Of Standardized Clinical & Functional Remission Criteria In Schizophrenia

You must be logged-in to view this content.

The Nature Of Relapse In Schizophrenia

You must be logged-in to view this content.

Predicting Engagement With Services For Psychosis: Insight, Symptoms & Recovery Style

You must be logged-in to view this content.

Are There Clinically Useful Predictors & Early Warning Signs For Pending Relapse?

You must be logged-in to view this content.

Validating A Brief Version Of The Mental Health Recovery Measure For Individuals With Schizophrenia

You must be logged-in to view this content.

Why Are The Outcomes In Patients With Schizophrenia So Poor?

You must be logged-in to view this content.

The Onset & Offset Of Psychosis – & What Happens In Between

You must be logged-in to view this content.

Recovery In Psychosis: A Delphi Study With Experts By Experience

You must be logged-in to view this content.

Assessing Early Signs Of Relapse In Psychosis: Review & Future Directions

You must be logged-in to view this content.

Using Longitudinal Imaging To Map The ‘Relapse Signature’ Of Schizophrenia & Other Psychoses

You must be logged-in to view this content.

The Importance Of Adherence To Long-Term Success In Schizophrenia

You must be logged-in to view this content.

Measurements Of Response, Remission & Recovery In Schizophrenia & Examples For Their Clinical Application

You must be logged-in to view this content.